First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report - Quiz - MDSpire

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report

  • By

  • Xiaoling Zhu

  • Yinan Yu

  • Wei Si

  • Jun Xu

  • July 14, 2026

Share

Original Source(s)

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report

  • by Xiaoling Zhu, Yinan Yu, Wei Si, Jun Xu

  • July 14, 2026

Related Content

An integrative naturopathic oncology approach in metastatic malignant melanoma: two case reports

What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis

Trends in liver failure-related mortality among middle-aged and older adults with digestive system malignant tumors in the United States, 1999–2023